The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anisodamine Market Research Report 2025
Synopsis
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Global Anisodamine market is projected to reach US$ 104.7 million in 2029, increasing from US$ 79 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anisodamine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anisodamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
ALB Technology Limited
Northeast Pharmaceutical Group
Dayang chem (Hangzhou)
Wuhan WUJING MEDICINE
Hangzhou Minsheng Pharmaceutical
HENAN PURUI MEDICINE
BRILLIANT PHARMACEUTICALS
Qingdao Huanghai Pharmaceutical
Nanjing Tianlang Pharmaceutical
Henan Kangqian Medical Technology
Shanghai yuanye Bio-Technology
Wsembio
Segment by Type
Injection
Tablet
Drops
Segment by Application
Visceral
Brain
Eyes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anisodamine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Anisodamine, also known as 7β-hydroxyhyoscyamine, is an anticholinergic and α1 adrenergic receptor antagonist used in the treatment of acute circulatory shock in China. It is given orally or by injection, as a racemic mixture (racanisodamine) or as a hydrobromide salt.
Global Anisodamine market is projected to reach US$ 104.7 million in 2029, increasing from US$ 79 million in 2022, with the CAGR of 3.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anisodamine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anisodamine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
ALB Technology Limited
Northeast Pharmaceutical Group
Dayang chem (Hangzhou)
Wuhan WUJING MEDICINE
Hangzhou Minsheng Pharmaceutical
HENAN PURUI MEDICINE
BRILLIANT PHARMACEUTICALS
Qingdao Huanghai Pharmaceutical
Nanjing Tianlang Pharmaceutical
Henan Kangqian Medical Technology
Shanghai yuanye Bio-Technology
Wsembio
Segment by Type
Injection
Tablet
Drops
Segment by Application
Visceral
Brain
Eyes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Anisodamine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Anisodamine Market Overview
1.1 Product Overview and Scope of Anisodamine
1.2 Anisodamine Segment by Type
1.2.1 Global Anisodamine Market Value Comparison by Type (2023-2029)
1.2.2 Injection
1.2.3 Tablet
1.2.4 Drops
1.3 Anisodamine Segment by Application
1.3.1 Global Anisodamine Market Value by Application: (2023-2029)
1.3.2 Visceral
1.3.3 Brain
1.3.4 Eyes
1.3.5 Others
1.4 Global Anisodamine Market Size Estimates and Forecasts
1.4.1 Global Anisodamine Revenue 2018-2029
1.4.2 Global Anisodamine Sales 2018-2029
1.4.3 Global Anisodamine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anisodamine Market Competition by Manufacturers
2.1 Global Anisodamine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anisodamine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anisodamine Average Price by Manufacturers (2018-2023)
2.4 Global Anisodamine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anisodamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anisodamine, Product Type & Application
2.7 Anisodamine Market Competitive Situation and Trends
2.7.1 Anisodamine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anisodamine Players Market Share by Revenue
2.7.3 Global Anisodamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anisodamine Retrospective Market Scenario by Region
3.1 Global Anisodamine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anisodamine Global Anisodamine Sales by Region: 2018-2029
3.2.1 Global Anisodamine Sales by Region: 2018-2023
3.2.2 Global Anisodamine Sales by Region: 2024-2029
3.3 Global Anisodamine Global Anisodamine Revenue by Region: 2018-2029
3.3.1 Global Anisodamine Revenue by Region: 2018-2023
3.3.2 Global Anisodamine Revenue by Region: 2024-2029
3.4 North America Anisodamine Market Facts & Figures by Country
3.4.1 North America Anisodamine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anisodamine Sales by Country (2018-2029)
3.4.3 North America Anisodamine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anisodamine Market Facts & Figures by Country
3.5.1 Europe Anisodamine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anisodamine Sales by Country (2018-2029)
3.5.3 Europe Anisodamine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anisodamine Market Facts & Figures by Country
3.6.1 Asia Pacific Anisodamine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anisodamine Sales by Country (2018-2029)
3.6.3 Asia Pacific Anisodamine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anisodamine Market Facts & Figures by Country
3.7.1 Latin America Anisodamine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anisodamine Sales by Country (2018-2029)
3.7.3 Latin America Anisodamine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anisodamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Anisodamine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anisodamine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anisodamine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anisodamine Sales by Type (2018-2029)
4.1.1 Global Anisodamine Sales by Type (2018-2023)
4.1.2 Global Anisodamine Sales by Type (2024-2029)
4.1.3 Global Anisodamine Sales Market Share by Type (2018-2029)
4.2 Global Anisodamine Revenue by Type (2018-2029)
4.2.1 Global Anisodamine Revenue by Type (2018-2023)
4.2.2 Global Anisodamine Revenue by Type (2024-2029)
4.2.3 Global Anisodamine Revenue Market Share by Type (2018-2029)
4.3 Global Anisodamine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anisodamine Sales by Application (2018-2029)
5.1.1 Global Anisodamine Sales by Application (2018-2023)
5.1.2 Global Anisodamine Sales by Application (2024-2029)
5.1.3 Global Anisodamine Sales Market Share by Application (2018-2029)
5.2 Global Anisodamine Revenue by Application (2018-2029)
5.2.1 Global Anisodamine Revenue by Application (2018-2023)
5.2.2 Global Anisodamine Revenue by Application (2024-2029)
5.2.3 Global Anisodamine Revenue Market Share by Application (2018-2029)
5.3 Global Anisodamine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Anisodamine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 ALB Technology Limited
6.2.1 ALB Technology Limited Corporation Information
6.2.2 ALB Technology Limited Description and Business Overview
6.2.3 ALB Technology Limited Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ALB Technology Limited Anisodamine Product Portfolio
6.2.5 ALB Technology Limited Recent Developments/Updates
6.3 Northeast Pharmaceutical Group
6.3.1 Northeast Pharmaceutical Group Corporation Information
6.3.2 Northeast Pharmaceutical Group Description and Business Overview
6.3.3 Northeast Pharmaceutical Group Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Northeast Pharmaceutical Group Anisodamine Product Portfolio
6.3.5 Northeast Pharmaceutical Group Recent Developments/Updates
6.4 Dayang chem (Hangzhou)
6.4.1 Dayang chem (Hangzhou) Corporation Information
6.4.2 Dayang chem (Hangzhou) Description and Business Overview
6.4.3 Dayang chem (Hangzhou) Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dayang chem (Hangzhou) Anisodamine Product Portfolio
6.4.5 Dayang chem (Hangzhou) Recent Developments/Updates
6.5 Wuhan WUJING MEDICINE
6.5.1 Wuhan WUJING MEDICINE Corporation Information
6.5.2 Wuhan WUJING MEDICINE Description and Business Overview
6.5.3 Wuhan WUJING MEDICINE Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Wuhan WUJING MEDICINE Anisodamine Product Portfolio
6.5.5 Wuhan WUJING MEDICINE Recent Developments/Updates
6.6 Hangzhou Minsheng Pharmaceutical
6.6.1 Hangzhou Minsheng Pharmaceutical Corporation Information
6.6.2 Hangzhou Minsheng Pharmaceutical Description and Business Overview
6.6.3 Hangzhou Minsheng Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hangzhou Minsheng Pharmaceutical Anisodamine Product Portfolio
6.6.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
6.7 HENAN PURUI MEDICINE
6.6.1 HENAN PURUI MEDICINE Corporation Information
6.6.2 HENAN PURUI MEDICINE Description and Business Overview
6.6.3 HENAN PURUI MEDICINE Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HENAN PURUI MEDICINE Anisodamine Product Portfolio
6.7.5 HENAN PURUI MEDICINE Recent Developments/Updates
6.8 BRILLIANT PHARMACEUTICALS
6.8.1 BRILLIANT PHARMACEUTICALS Corporation Information
6.8.2 BRILLIANT PHARMACEUTICALS Description and Business Overview
6.8.3 BRILLIANT PHARMACEUTICALS Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 BRILLIANT PHARMACEUTICALS Anisodamine Product Portfolio
6.8.5 BRILLIANT PHARMACEUTICALS Recent Developments/Updates
6.9 Qingdao Huanghai Pharmaceutical
6.9.1 Qingdao Huanghai Pharmaceutical Corporation Information
6.9.2 Qingdao Huanghai Pharmaceutical Description and Business Overview
6.9.3 Qingdao Huanghai Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Qingdao Huanghai Pharmaceutical Anisodamine Product Portfolio
6.9.5 Qingdao Huanghai Pharmaceutical Recent Developments/Updates
6.10 Nanjing Tianlang Pharmaceutical
6.10.1 Nanjing Tianlang Pharmaceutical Corporation Information
6.10.2 Nanjing Tianlang Pharmaceutical Description and Business Overview
6.10.3 Nanjing Tianlang Pharmaceutical Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nanjing Tianlang Pharmaceutical Anisodamine Product Portfolio
6.10.5 Nanjing Tianlang Pharmaceutical Recent Developments/Updates
6.11 Henan Kangqian Medical Technology
6.11.1 Henan Kangqian Medical Technology Corporation Information
6.11.2 Henan Kangqian Medical Technology Anisodamine Description and Business Overview
6.11.3 Henan Kangqian Medical Technology Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Henan Kangqian Medical Technology Anisodamine Product Portfolio
6.11.5 Henan Kangqian Medical Technology Recent Developments/Updates
6.12 Shanghai yuanye Bio-Technology
6.12.1 Shanghai yuanye Bio-Technology Corporation Information
6.12.2 Shanghai yuanye Bio-Technology Anisodamine Description and Business Overview
6.12.3 Shanghai yuanye Bio-Technology Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Shanghai yuanye Bio-Technology Anisodamine Product Portfolio
6.12.5 Shanghai yuanye Bio-Technology Recent Developments/Updates
6.13 Wsembio
6.13.1 Wsembio Corporation Information
6.13.2 Wsembio Anisodamine Description and Business Overview
6.13.3 Wsembio Anisodamine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Wsembio Anisodamine Product Portfolio
6.13.5 Wsembio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anisodamine Industry Chain Analysis
7.2 Anisodamine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anisodamine Production Mode & Process
7.4 Anisodamine Sales and Marketing
7.4.1 Anisodamine Sales Channels
7.4.2 Anisodamine Distributors
7.5 Anisodamine Customers
8 Anisodamine Market Dynamics
8.1 Anisodamine Industry Trends
8.2 Anisodamine Market Drivers
8.3 Anisodamine Market Challenges
8.4 Anisodamine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
